Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse model-Reference-Cited by-同舟云学术

Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse model

Published:2017-06 Issue:6 Volume:1863 Page:1596-1604
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Bichell Terry Jo V.,Wegrzynowicz Michal,Tipps K. Grace,Bradley Emma M.,Uhouse Michael A.,Bryan Miles,Horning Kyle,Fisher Nicole,Dudek Karrie,Halbesma Timothy,Umashanker Preethi,Stubbs Andrew D.,Holt Hunter K.,Kwakye Gunnar F.,Tidball Andrew M.,Colbran Roger J.,Aschner Michael,Neely M. Diana,Di Pardo Alba,Maglione Vittorio,Osmand Alexander,Bowman Aaron B.

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference39 articles.

1. Disease-toxicant screen reveals a neuroprotective interaction between Huntington's disease and manganese exposure;Williams;J. Neurochem.,2010

2. Manganese is essential for neuronal health;Horning;Annu. Rev. Nutr.,2015

3. A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease;Tidball;Hum. Mol. Genet.,2015

4. Alterations in brain transition metals in Huntington disease: an evolving and intricate story;Rosas;Arch. Neurol.,2012

5. The neuropathology of manganese-induced Parkinsonism;Perl;J. Neuropathol. Exp. Neurol.,2007

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How a midwife became a neuroscientist to seek a cure for her son;Nature;2024-08-20

2. Gray matter morphometric biomarkers for distinguishing manganese-exposed welders from healthy adults revealed by source-based morphometry;NeuroToxicology;2024-07

3. Alterations in Cerebrospinal Fluid Urea Occur in Late Manifest Huntington’s Disease;Journal of Huntington's Disease;2024-03-29

4. Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington’s disease;Molecular Therapy;2023-01

5. Alterations in metal homeostasis occur prior to canonical markers in Huntington disease;Scientific Reports;2022-06-20